These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3499654)

  • 1. The control of experimental allergic encephalomyelitis with retinoic acid. Further studies.
    Massacesi L; Abbamondi AL; Sarlo F; Amaducci L
    Riv Neurol; 1987; 57(3):166-9. PubMed ID: 3499654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by retinoic acid.
    Massacesi L; Abbamondi AL; Giorgi C; Sarlo F; Lolli F; Amaducci L
    J Neurol Sci; 1987 Aug; 80(1):55-64. PubMed ID: 3497230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
    Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
    J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats.
    Hoffman GE; Le WW; Murphy AZ; Koski CL
    Exp Neurol; 2001 Oct; 171(2):272-84. PubMed ID: 11573979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
    Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
    J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
    Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
    J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of experimental allergic encephalomyelitis during steroid administration. Outcome of neurological immune-mediated disorders under immunosuppressive therapy.
    Steiner I; Brenner T; Mizrachi-Kol R; Abramsky O
    Isr J Med Sci; 1991 Jul; 27(7):365-8. PubMed ID: 2071371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1, 25-dihydroxyvitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis: experiment with rats].
    Jiao ZM; Fu YH; Fu J; Zhang F; Wang WZ
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2350-4. PubMed ID: 19087699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
    Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
    Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
    McCombe PA; Nickson I; Tabi Z; Pender MP
    J Neurol Sci; 1996 Jul; 139(1):1-6. PubMed ID: 8836965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
    Mohamed A; Reid PF; Raymond L; Dufan T
    Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.